197 related articles for article (PubMed ID: 25110949)
21. Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients.
Soldan SS; Leist TP; Juhng KN; McFarland HF; Jacobson S
Ann Neurol; 2000 Mar; 47(3):306-13. PubMed ID: 10716249
[TBL] [Abstract][Full Text] [Related]
22. Serological examination of human herpesvirus 6 and 7 in patients with coronary artery disease.
Ihira M; Yoshikawa T; Ishii J; Nomura M; Hishida H; Ohashi M; Enomoto Y; Suga S; Iida K; Saito Y; Nishiyama Y; Asano Y
J Med Virol; 2002 Aug; 67(4):534-7. PubMed ID: 12116000
[TBL] [Abstract][Full Text] [Related]
23. Multiple sclerosis and human herpesvirus 6.
Gutiérrez J; Vergara MJ; Guerrero M; Fernández O; Piédrola G; Morales P; Maroto MC
Infection; 2002 Jun; 30(3):145-9. PubMed ID: 12120939
[TBL] [Abstract][Full Text] [Related]
24. Comparison of specific serological assays for diagnosing human herpesvirus 6 infection after liver transplantation.
Yoshikawa T; Black JB; Ihira M; Suzuki K; Suga S; Iida K; Saito Y; Asonuma K; Tanaka K; Asano Y
Clin Diagn Lab Immunol; 2001 Jan; 8(1):170-3. PubMed ID: 11139213
[TBL] [Abstract][Full Text] [Related]
25. The immune response against herpesvirus is more prominent in the early stages of MS.
Villoslada P; Juste C; Tintore M; Llorenç V; Codina G; Pozo-Rosich P; Montalban X
Neurology; 2003 Jun; 60(12):1944-8. PubMed ID: 12821737
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of human herpesvirus U94/REP antibodies and DNA in Tunisian multiple sclerosis patients.
Ben-Fredj N; Ben-Selma W; Rotola A; Nefzi F; Benedetti S; Frih-Ayed M; Di Luca D; Aouni M; Caselli E
J Neurovirol; 2013 Feb; 19(1):42-7. PubMed ID: 23179681
[TBL] [Abstract][Full Text] [Related]
27. Correlation between anti-JC-virus and anti-cytomegalovirus, -Epstein-Barr virus and -measles/-rubella/-varicella-zoster-virus antibodies.
Auer M; Borena W; Holm-von Laer D; Deisenhammer F
J Med Virol; 2017 Jan; 89(1):3-9. PubMed ID: 27253624
[TBL] [Abstract][Full Text] [Related]
28. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA.
Soldan SS; Berti R; Salem N; Secchiero P; Flamand L; Calabresi PA; Brennan MB; Maloni HW; McFarland HF; Lin HC; Patnaik M; Jacobson S
Nat Med; 1997 Dec; 3(12):1394-7. PubMed ID: 9396611
[TBL] [Abstract][Full Text] [Related]
29. Dual antibody rises to cytomegalovirus and human herpesvirus type 6: frequency of occurrence in CMV infections and evidence for genuine reactivity to both viruses.
Irving WL; Ratnamohan VM; Hueston LC; Chapman JR; Cunningham AL
J Infect Dis; 1990 May; 161(5):910-6. PubMed ID: 2157772
[TBL] [Abstract][Full Text] [Related]
30. Detection of IgM antibodies to human herpesvirus 6 in Romanian children with nonprogressive human immunodeficiency virus disease.
Nigro G; Luzi G; Krzysztofiak A; D'Orio F; Aiuti F
Pediatr Infect Dis J; 1995 Oct; 14(10):891-4. PubMed ID: 8584318
[TBL] [Abstract][Full Text] [Related]
31. Identification of the major HHV-6 antigen recognized by cerebrospinal fluid IgG in multiple sclerosis.
Alenda R; Álvarez-Lafuente R; Costa-Frossard L; Arroyo R; Mirete S; Álvarez-Cermeño JC; Villar LM
Eur J Neurol; 2014 Aug; 21(8):1096-1101. PubMed ID: 24724742
[TBL] [Abstract][Full Text] [Related]
32. MHC2TA rs4774C and HHV-6A active replication in multiple sclerosis patients.
Alvarez-Lafuente R; Martinez A; Garcia-Montojo M; Mas A; De Las Heras V; Dominguez-Mozo MI; Maria Del Carmen C; López-Cavanillas M; Bartolome M; Gomez de la Concha E; Urcelay E; Arroyo R
Eur J Neurol; 2010 Jan; 17(1):129-35. PubMed ID: 19659749
[TBL] [Abstract][Full Text] [Related]
33. The Neutralizing Linear Epitope of Human Herpesvirus 6A Glycoprotein B Does Not Affect Virus Infectivity.
Wakata A; Kanemoto S; Tang H; Kawabata A; Nishimura M; Jasirwan C; Mahmoud NF; Mori Y
J Virol; 2018 Mar; 92(5):. PubMed ID: 29212944
[TBL] [Abstract][Full Text] [Related]
34. Serological response of paediatric oncology patients to human herpesvirus-6.
Lyall EG
J Med Virol; 1994 Aug; 43(4):373-9. PubMed ID: 7964647
[TBL] [Abstract][Full Text] [Related]
35. Anti-viral properties of interferon beta treatment in patients with multiple sclerosis.
Hong J; Tejada-Simon MV; Rivera VM; Zang YC; Zhang JZ
Mult Scler; 2002 May; 8(3):237-42. PubMed ID: 12120696
[TBL] [Abstract][Full Text] [Related]
36. Natalizumab treatment decreases serum IgM and IgG levels in multiple sclerosis patients.
Selter RC; Biberacher V; Grummel V; Buck D; Eienbröker C; Oertel WH; Berthele A; Tackenberg B; Hemmer B
Mult Scler; 2013 Oct; 19(11):1454-61. PubMed ID: 23439578
[TBL] [Abstract][Full Text] [Related]
37. Inherited Chromosomally Integrated Human Herpesvirus 6 Demonstrates Tissue-Specific RNA Expression
Peddu V; Dubuc I; Gravel A; Xie H; Huang ML; Tenenbaum D; Jerome KR; Tardif JC; Dubé MP; Flamand L; Greninger AL
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597766
[TBL] [Abstract][Full Text] [Related]
38. IgM and avidity of IgG antibodies in primary HHV-6 infections.
Salonen MJ; Vaheri A; Koskiniemi M
Scand J Infect Dis; 2008; 40(5):420-3. PubMed ID: 18418803
[TBL] [Abstract][Full Text] [Related]
39. Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis.
Grut V; Biström M; Salzer J; Stridh P; Jons D; Gustafsson R; Fogdell-Hahn A; Huang J; Butt J; Lindam A; Alonso-Magdalena L; Bergström T; Kockum I; Waterboer T; Olsson T; Zetterberg H; Blennow K; Andersen O; Nilsson S; Sundström P
Brain; 2024 Jan; 147(1):177-185. PubMed ID: 37930324
[TBL] [Abstract][Full Text] [Related]
40. Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patients.
Yao K; Gagnon S; Akhyani N; Williams E; Fotheringham J; Frohman E; Stuve O; Monson N; Racke MK; Jacobson S
PLoS One; 2008 Apr; 3(4):e2028. PubMed ID: 18446218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
